SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Basilea Pharmaceutica Initiates Multiple Ascending Dose Phase I Study With Novel Antibiotic BAL30072 Active against Multidrug-Resistant Gram-Negative Bacteria